 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 October 1995 | Volume 123 Issue 8 | Pages 615-620
Purpose: To review the available data on the association between hepatitis C virus (HCV) infection and conditions reportedly related to infection with the virus and to assess the clinical implications of these associations.
Data Sources: Pertinent articles were identified using the Paperchase database, which simultaneously searches the MEDLINE (1966 to present), Health (1975 to present), AIDSLINE (1980 to present), and Cancerlit databases.
Study Selection: All studies for a given association were reviewed, but special attention was paid to randomized controlled trials where applicable.
Results: According to the available data, HCV infection appears to be strongly associated with essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda. Evidence strongly suggests that HCV has a direct pathogenetic role in some patients with the first two conditions. The association with Mooren corneal ulcers and autoimmune thyroiditis is suggested, but more data are needed to confirm it. The data for the association between HCV infection and the Sjogren syndrome, lichen planus, and idiopathic pulmonary fibrosis remain weak. Although interferon therapy has been effective in patients with both essential mixed cryoglobulinemia and membranoproliferative glomerulonephritis, a high relapse rate has been noted in the latter condition.
Conclusions: Patients with essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda should be tested for HCV infection. Conversely, signs and symptoms of these conditions should be sought in patients with chronic HCV infection. Interferon therapy is currently recommended only for patients with symptomatic essential mixed cryoglobulinemia.
Author and Article Information
From Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts.
REVIEW
Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations
Requests for Reprints: Sanjiv Chopra, MD, Division of Gastroenterology, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02215.
Current Author Addresses: Dr. Chopra: Division of Gastroenterology, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02215. Dr. Gumber: Eastern Digestive Diseases Center, Inc., 796-B Moye Boulevard, Greenville, NC 27835.
This article has been cited by other articles:
|
|
 |
|
  J. I. Tsui, E. Vittinghoff, M. G. Shlipak, D. Bertenthal, J. Inadomi, R. A. Rodriguez, and A. M. O'Hare Association of Hepatitis C Seropositivity With Increased Risk for Developing End-stage Renal Disease Arch Intern Med, June 25, 2007; 167(12): 1271 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Miyamoto, K. Moriishi, K. Moriya, S. Murata, K. Tanaka, T. Suzuki, T. Miyamura, K. Koike, and Y. Matsuura Involvement of the PA28{gamma}-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein J. Virol., February 15, 2007; 81(4): 1727 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Santoro, F Manganelli, C Briani, F Giannini, L Benedetti, E Vitelli, A Mazzeo, E Beghi, and HCV Peripheral Nerve Study Group Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 626 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lecube, C. Hernandez, J. Genesca, and R. Simo Glucose Abnormalities in Patients with Hepatitis C Virus Infection: Epidemiology and pathogenesis Diabetes Care, May 1, 2006; 29(5): 1140 - 1149. [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Tsui, E. Vittinghoff, M. G. Shlipak, and A. M. O'Hare Relationship between Hepatitis C and Chronic Kidney Disease: Results from the Third National Health and Nutrition Examination Survey J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1168 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wong and S. S. Lee Hepatitis C: a review for primary care physicians Can. Med. Assoc. J., February 28, 2006; 174(5): 649 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Piche, G Vanbiervliet, F Cherikh, Z Antoun, P M Huet, E Gelsi, J-F Demarquay, F-X Caroli-Bosc, S Benzaken, M-C Rigault, et al. Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study Gut, August 1, 2005; 54(8): 1169 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tisdale, A. Mahadevan, and R. H. Matthews T-Cell Lymphoma of the Rectum in a Patient with AIDS and Hepatitis C: A Case Report and Discussion Oncologist, April 1, 2005; 10(4): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ito, H. Ito, M. Nagano, S. Nakano, Y. Shigeyoshi, and H. Kusaka In situ identification of hepatitis C virus RNA in muscle Neurology, March 22, 2005; 64(6): 1073 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Ramos-Casals and J Font Mycophenolate mofetil in patients with hepatitis C virus infection Lupus, March 1, 2005; 14(3_suppl): s64 - s72. [Abstract] [PDF]
|
|
|
|
|
|
M. Ramos-Casals and J. Font Mycophenolate mofetil in patients with hepatitis C virus infection Lupus, January 1, 2005; 14(1_suppl): s64 - s72. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Antonelli, C. Ferri, P. Fallahi, D. Giuggioli, C. Nesti, G. Longombardo, P. Fadda, A. Pampana, M. Maccheroni, and E. Ferrannini Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia QJM, August 1, 2004; 97(8): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Peffault de Latour, V. Levy, T. Asselah, P. Marcellin, C. Scieux, L. Ades, R. Traineau, A. Devergie, P. Ribaud, H. Esperou, et al. Long-term outcome of hepatitis C infection after bone marrow transplantation Blood, March 1, 2004; 103(5): 1618 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Antonelli, C. Ferri, P. Fallahi, M. Sebastiani, C. Nesti, L. Barani, R. Barale, and E. Ferrannini Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients Rheumatology, February 1, 2004; 43(2): 238 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Aljurf, T. W. Owaidah, A. Ezzat, E. Ibrahim, and A. Tbakhi Antigen- and/or immune-driven lymphoproliferative disorders Ann. Onc., November 1, 2003; 14(11): 1595 - 1606. [Full Text] [PDF]
|
|
|
|
|
|
E. Zuckerman, A. Kessel, G. Slobodin, E. Sabo, D. Yeshurun, and E. Toubi Antiviral Treatment Down-Regulates Peripheral B-Cell CD81 Expression and CD5 Expansion in Chronic Hepatitis C Virus Infection J. Virol., October 1, 2003; 77(19): 10432 - 10436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ramos-Casals, O. Trejo, M. Garcia-Carrasco, and J. Font Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection Rheumatology, July 1, 2003; 42(7): 818 - 828. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Sabry, M. A. Sobh, H. A. Sheaashaa, G. Kudesia, G. Wild, S. Fox, B. E. Wagner, W. L. Irving, A. Grabowska, and A. M. El-Nahas Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1924 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Piche, E Gelsi, S M Schneider, X Hebuterne, J Giudicelli, B Ferrua, C Laffont, S Benzaken, P Hastier, M L Montoya, et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C Gut, September 1, 2002; 51(3): 434 - 439. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Ferri, M. A. Bertozzi, and A. L. Zignego Erectile Dysfunction and Hepatitis C Virus Infection JAMA, August 14, 2002; 288(6): 698 - 699. [Full Text] [PDF]
|
|
|
|
|
|
N. Costedoat-Chalumeau, P. Cacoub, T. Maisonobe, V. Thibault, P. Cluzel, M. Gatfosse, Z. Amoura, and J.-C. Piette Renal microaneurysms in three cases of hepatitis C virus-related vasculitis Rheumatology, June 1, 2002; 41(6): 708 - 710. [Full Text] [PDF]
|
|
|
|
 |
|
 C Ferri, A L Zignego, and S A Pileri Cryoglobulins J. Clin. Pathol., January 1, 2002; 55(1): 4 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Barrett, J Goh, B Coughlan, E Ryan, S Stewart, A Cockram, J C O'Keane, and J Crowe The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection Gut, September 1, 2001; 49(3): 423 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Racanelli, D. Sansonno, C. Piccoli, F. P. D'Amore, F. A. Tucci, and F. Dammacco Molecular Characterization of B Cell Clonal Expansions in the Liver of Chronically Hepatitis C Virus-Infected Patients J. Immunol., July 1, 2001; 167(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Lidove, P Cacoub, T Maisonobe, J Servan, V Thibault, J-C Piette, and J-M Leger Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia Ann Rheum Dis, March 1, 2001; 60(3): 290 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. M Sthoeger, M. Fogel, A. Smirov, D. Ergas, Y. Lurie, D. D Bass, D. Geltner, and S. D H Malnick Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection Ann Rheum Dis, June 1, 2000; 59(6): 483 - 486. [Abstract] [Full Text]
|
|
|
|
|
|
J. SOMA, T. SAITO, Y. TAGUMA, S. CHIBA, H. SATO, K. SUGIMURA, S. OGAWA, and S. ITO High Prevalence and Adverse Effect of Hepatitis C Virus Infection in Type II Diabetic-Related Nephropathy J. Am. Soc. Nephrol., April 1, 2000; 11(4): 690 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Migliaresi, A. Bresciani, L. Ambrosone, M. Spera, D. Barbarulo, V. Lombari, G. Pirozzi, G. Borgia, M. L. Lombardi, G. Tirri, et al. Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia Ann Rheum Dis, January 1, 2000; 59(1): 20 - 25. [Abstract] [Full Text]
|
|
|
|
|
|
R Perniola, C De Rinaldis, E Accogli, and G Lobreglio Prevalence and clinical features of cryoglobulinaemia in multitransfused beta -thalassaemia patients Ann Rheum Dis, November 1, 1999; 58(11): 698 - 702. [Abstract] [Full Text]
|
|
|
|
|
|
A. Antonelli, C. Ferri, and P. Fallahi Thyroid Cancer in Patients With Hepatitis C Infection JAMA, May 5, 1999; 281(17): 1588 - 1588. [Full Text] [PDF]
|
|
|
|
|
|
C Ferri, L La Civita, G Longombardo, A L Zignego, and G Pasero Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders Lupus, May 1, 1998; 7(4): 275 - 279. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi Chronic Variant of Myocarditis Associated With Hepatitis C Virus Infection Circulation, July 1, 1997; 96(1): 22 - 24. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Koike, K. Moriya, K. Ishibashi, H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Kurokawa, Y. Matsuura, and T. Miyamura Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes PNAS, January 7, 1997; 94(1): 233 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Buskila, E. Sikuler, and Y. Shoenfeld Review: Hepatitis C virus, autoimmunity and rheumatic disease Lupus, January 1, 1997; 6(9): 685 - 689. [PDF]
|
|
Article
